KR900700607A - 면역학적 주효체 세포 활성화 및 화학적 인력을 유발하는 단백질 - Google Patents

면역학적 주효체 세포 활성화 및 화학적 인력을 유발하는 단백질

Info

Publication number
KR900700607A
KR900700607A KR1019890701872A KR890701872A KR900700607A KR 900700607 A KR900700607 A KR 900700607A KR 1019890701872 A KR1019890701872 A KR 1019890701872A KR 890701872 A KR890701872 A KR 890701872A KR 900700607 A KR900700607 A KR 900700607A
Authority
KR
South Korea
Prior art keywords
protein
cell activation
immune cell
induces immune
chemical attraction
Prior art date
Application number
KR1019890701872A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR900700607A publication Critical patent/KR900700607A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1019890701872A 1988-02-09 1989-10-11 면역학적 주효체 세포 활성화 및 화학적 인력을 유발하는 단백질 KR900700607A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/153,887 US5049659A (en) 1988-02-09 1988-02-09 Proteins which induce immunological effector cell activation and chemattraction
PCT/US1989/000496 WO1989007613A1 (en) 1988-02-09 1989-02-08 Proteins which induce immunological effector cell activation and chemattraction

Publications (1)

Publication Number Publication Date
KR900700607A true KR900700607A (ko) 1990-08-16

Family

ID=22549146

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890701872A KR900700607A (ko) 1988-02-09 1989-10-11 면역학적 주효체 세포 활성화 및 화학적 인력을 유발하는 단백질

Country Status (8)

Country Link
US (1) US5049659A (ko)
EP (1) EP0406257A4 (ko)
JP (1) JPH03502453A (ko)
KR (1) KR900700607A (ko)
AU (1) AU628806B2 (ko)
DK (1) DK189090A (ko)
FI (1) FI903929A0 (ko)
WO (1) WO1989007613A1 (ko)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0391928B1 (en) * 1987-09-28 1993-12-01 La Jolla Cancer Research Foundation Selection for cells having increased cell adhesion properties
IL88831A0 (en) * 1988-12-29 1989-07-31 Yeda Res & Dev Blood assay
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5304496A (en) * 1991-06-10 1994-04-19 Children's Hospital Of Philadelphia Biological regulation of mineralization
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5268364A (en) * 1991-12-12 1993-12-07 The Biomembrane Institute Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification
ES2185630T3 (es) * 1992-04-30 2003-05-01 Innogenetics Nv Nuevos polipeptidos y peptidos, acidos nucleicos que los codifican, y su utilizacion en el campo de la terapia de tumores, inflamacion o inmunologia.
DE4310632A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Lineare Adhäsionsinhibitoren
US5695761A (en) * 1993-12-23 1997-12-09 Rutgers University Suppression of nitric oxide production by osteopontin
US6159748A (en) * 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
IL114140A (en) * 1995-06-14 2000-06-01 Hadasit Med Res Service Anti-metastatic and anti-angiogenetic pharmaceutical compositions
US5837247A (en) * 1995-06-16 1998-11-17 United States Of America As Represented By The Public Health Service National Institutes Of Health Chemotactic agents for t-cells
US6995018B1 (en) * 1999-04-09 2006-02-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Complex formed by N-linked glycoproteins (SIBLINGS)and Factor H
EP1175442A2 (en) * 1999-04-15 2002-01-30 Children's Medical Center Corporation Osteopontin-derived chemotactic and inhibitory agents and uses therefor
EP1173469A2 (en) * 1999-04-16 2002-01-23 Children's Medical Center Corporation Adhesion modulatory peptides and methods for use
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US20050048614A1 (en) * 2000-06-13 2005-03-03 Children's Medical Center Corporation Biosynthetic oncolytic molecules and uses therefor
US20060105013A1 (en) * 2000-10-18 2006-05-18 Samy Ashkar Osteopontin-coated surfaces and methods of use
AU2003258127A1 (en) 2002-08-06 2004-02-23 Diadexus, Inc. Compositions and methods relating to ovarian specific genes and proteins
JP2007530586A (ja) 2004-03-25 2007-11-01 ザ ファインスタイン インスティテュート フォー メディカル リサーチ 神経性止血法
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
CN102793972A (zh) 2004-12-27 2012-11-28 范因斯坦医学研究院 通过电刺激迷走神经治疗炎症性疾病
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US8391970B2 (en) * 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
WO2009146030A1 (en) 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of t-cell activity
ES2452484T3 (es) 2008-11-18 2014-04-01 Setpoint Medical Corporation Dispositivos para optimizar la colocación de electrodos para la estimulación antiinflamatoria
US20110054569A1 (en) * 2009-09-01 2011-03-03 Zitnik Ralph J Prescription pad for treatment of inflammatory disorders
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
EP2440284B1 (en) 2009-06-09 2018-09-12 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
WO2014169145A1 (en) 2013-04-10 2014-10-16 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
EP2515996B1 (en) 2009-12-23 2019-09-18 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
EP2707094B1 (en) 2011-05-09 2016-02-03 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en) 2015-02-03 2022-08-09 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
WO2017127758A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
EP3405107B1 (en) 2016-01-20 2023-04-12 Setpoint Medical Corporation Control of vagal stimulation
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
WO2019036470A1 (en) 2017-08-14 2019-02-21 Setpoint Medical Corporation TESTING TEST FOR STIMULATION OF NERVE WAVE
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
WO2021236977A1 (en) 2020-05-21 2021-11-25 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide

Also Published As

Publication number Publication date
DK189090D0 (da) 1990-08-08
US5049659A (en) 1991-09-17
FI903929A0 (fi) 1990-08-08
WO1989007613A1 (en) 1989-08-24
DK189090A (da) 1990-10-08
EP0406257A1 (en) 1991-01-09
AU628806B2 (en) 1992-09-24
AU3192989A (en) 1989-09-06
JPH03502453A (ja) 1991-06-06
EP0406257A4 (en) 1993-03-31

Similar Documents

Publication Publication Date Title
KR900700607A (ko) 면역학적 주효체 세포 활성화 및 화학적 인력을 유발하는 단백질
IT1205010B (it) Tetraidronaftalin-derivati e indan-derivati
TR22746A (tr) Hidrokarbon doenuestuerme yoentemi ve katalizoerleri
DK2189A (da) Kimaere antistoffer samt deres fremstilling og anvendelse
KR900700343A (ko) 파라세일링 조립체 및 그의 발사장치
KR880700194A (ko) 콘테이너 밸브 및 콘테이너
DK307986D0 (da) Klonet antigen
DE3788807D1 (de) Fusionsproteine und -partikel.
MX4286A (es) Polioles poliester y procedimiento de preparacion.
DK639988D0 (da) Peptider samt anvendelse deraf.
DK190889D0 (da) Antigen
DK172686D0 (da) Antigen
NO895031L (no) 2-imino-6-polyfluoralkoksybenzotiazol samt fremstilling derav.
DK21586D0 (da) Antigener og antistoffer samt praeparater indeholdende disse
KR890016710U (ko) 솔레노이드
DK492588D0 (da) Antigen-polypeptider
IT8519513A0 (it) Protesi di capelli
TR23414A (tr) Agartma ve parlaklastirma terkibi ve yoentemi
DK198888A (da) Immunoassay og saet dertil
TR24661A (tr) Piridiltio piridilsuelfinil ve piridil suelfonil- fenil-tiouereler izotiouereler ve
GB2210164B (en) Protein assay device and method
KR860013477U (ko) 봉 합 고 리
NO173340C (no) Humant protein C antistoff
IE882901L (en) Protein assay device and method
ES290721Y (es) Asiento plegable y transportable

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid